Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Malone

Showing results (41-50 of 239) with videos related to

Pageof 24
Sort By:
Journal of Health Economics and Outcomes Research|February 23, 2026
The Paradox of Life Extension with Traditional Cost-Effectiveness Analysis: A Case Study with Duchenne Muscular DystrophyLauren Sedita, Alexa Klimchak, Eleanor Perfetto, et al.
Pharmacotherapy|March 26, 2004
Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalizationJacob Abarca, Daniel C Malone, Edward P Armstrong, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 30, 2024
An evaluation of vilobelimab (anti-C5a) as a cost-effective option to treat severely ill mechanically ventilated patients with COVID-19Daniel C Malone, Joseph Biskupiak, Diana Brixner, et al.
Journal of Medical Economics|August 12, 2014
Costs and utilization of hemophilia A and B patients with and without inhibitorsEdward P Armstrong, Daniel C Malone, Sangeeta Krishnan, et al.
The Annals of Pharmacotherapy|July 27, 2006
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measuresLisa M Hess, Marsha A Raebel, Douglas A Conner, et al.
Therapeutic Advances in Chronic Disease|September 2, 2016
Prescribing attitudes, behaviors and opinions regarding metformin for patients with diabetes: a focus group studyKaty E Trinkley, Daniel C Malone, Jennifer A Nelson, et al.
American Journal of Alzheimer'S Disease and Other Dementias|December 1, 2012
Health disparities in cost of care in patients with Alzheimer's disease: an analysis across 4 state Medicaid populationsAdrienne M Gilligan, Daniel C Malone, Terri L Warholak, et al.
Journal of Medical Internet Research|December 1, 2022
Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record AnalysisSteven T Simon, Katy E Trinkley, Daniel C Malone, et al.
Stroke|April 4, 2013
Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillationAmanda R Harrington, Edward P Armstrong, Paul E Nolan, et al.
American Journal of Ophthalmology|May 14, 2016
Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle GlaucomaNeil M Schultz, William B Wong, Anne L Coleman, et al.
Pageof 24

Showing results (41-50 of 239) with videos related to

Sort By:
Pageof 24
Journal of Health Economics and Outcomes Research|February 23, 2026
The Paradox of Life Extension with Traditional Cost-Effectiveness Analysis: A Case Study with Duchenne Muscular DystrophyLauren Sedita, Alexa Klimchak, Eleanor Perfetto, et al.
Pharmacotherapy|March 26, 2004
Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalizationJacob Abarca, Daniel C Malone, Edward P Armstrong, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 30, 2024
An evaluation of vilobelimab (anti-C5a) as a cost-effective option to treat severely ill mechanically ventilated patients with COVID-19Daniel C Malone, Joseph Biskupiak, Diana Brixner, et al.
Journal of Medical Economics|August 12, 2014
Costs and utilization of hemophilia A and B patients with and without inhibitorsEdward P Armstrong, Daniel C Malone, Sangeeta Krishnan, et al.
The Annals of Pharmacotherapy|July 27, 2006
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measuresLisa M Hess, Marsha A Raebel, Douglas A Conner, et al.
Therapeutic Advances in Chronic Disease|September 2, 2016
Prescribing attitudes, behaviors and opinions regarding metformin for patients with diabetes: a focus group studyKaty E Trinkley, Daniel C Malone, Jennifer A Nelson, et al.
American Journal of Alzheimer'S Disease and Other Dementias|December 1, 2012
Health disparities in cost of care in patients with Alzheimer's disease: an analysis across 4 state Medicaid populationsAdrienne M Gilligan, Daniel C Malone, Terri L Warholak, et al.
Journal of Medical Internet Research|December 1, 2022
Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record AnalysisSteven T Simon, Katy E Trinkley, Daniel C Malone, et al.
Stroke|April 4, 2013
Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillationAmanda R Harrington, Edward P Armstrong, Paul E Nolan, et al.
American Journal of Ophthalmology|May 14, 2016
Predictors, Resource Utilization, and Short-term Costs of Laser Trabeculoplasty Versus Medication Management in Open-Angle GlaucomaNeil M Schultz, William B Wong, Anne L Coleman, et al.
Pageof 24